Continued Operating and Ordinary Losses

「However, full-year operating loss has been revised downward from the previous forecast of ¥1.45 billion to ¥1.52 billion, compared with an operating loss of ¥1.44 billion in the previous fiscal year, and the loss is expected to widen.」

「Operating loss was ¥1,445 million, compared with an operating loss of ¥1,384 million in the previous fiscal year. In addition, due to non-operating income and expenses, including ¥16 million in interest income and ¥41 million in gains on investment business partnerships, ordinary loss was ¥1,339 million, compared with ordinary loss of ¥1,261 million in the previous fiscal year. Due to the recording of ¥25 million in impairment loss on non-current assets as an extraordinary loss and other factors, net loss for the period was ¥1,362 million, compared with net loss of ¥1,276 million in the previous fiscal year.」

「Operating loss was ¥755 million, compared with an operating loss of ¥658 million in the same period of the previous year. In addition, due to non-operating income and expenses, including ¥30 million in gains on investment business partnerships, ordinary loss was ¥710 million, compared with ordinary loss of ¥632 million in the same period of the previous year, and interim net loss was ¥705 million, compared with interim net loss of ¥634 million in the same period of the previous year.」

「Operating loss was ¥658 million, compared with an operating loss of ¥671 million in the same period of the previous year. In addition, due to non-operating income and expenses and other factors, including ¥20 million in gains on investment business partnerships, compared with losses of ¥6 million in the same period of the previous year, ordinary loss was ¥632 million, compared with ordinary loss of ¥669 million in the same period of the previous year, and quarterly net loss was ¥634 million, compared with quarterly net loss of ¥676 million in the same period of the previous year.」

「Due to higher revenue and other factors, gross profit was ¥76 million, up 65.2% year on year, while lower general and administrative expenses, mainly due to lower commissions paid, resulted in selling, general and administrative expenses of ¥370 million, down 0.4%, and operating loss of ¥293 million, compared with an operating loss of ¥325 million in the same period of the previous year. In addition, due to non-operating income and expenses and other factors, including ¥2 million in income from processing interruptions, up 8.5% year on year, and ¥4 million in share issuance costs, compared with none in the same period of the previous year, ordinary loss was ¥291 million, compared with ordinary loss of ¥324 million in the same period of the previous year, and quarterly net loss was ¥292 million, compared with quarterly net loss of ¥325 million in the same period of the previous year.」

「Operating loss was ¥1,425 million, compared with an operating loss of ¥1,333 million in the previous fiscal year. In addition, due to non-operating income and expenses, including ¥11 million in income from processing interruptions, up 13.0% from the previous fiscal year, and ¥10 million in losses on investment business partnerships, compared with gains of ¥1 million in the previous fiscal year, ordinary loss was ¥1,419 million, compared with ordinary loss of ¥1,314 million in the previous fiscal year. Due to the recording of ¥16 million in loss on cancellation of insurance policies as an extraordinary loss and other factors, net loss for the period was ¥1,437 million, compared with net loss of ¥1,254 million in the previous fiscal year.」

「Operating loss was ¥1,046 million, compared with an operating loss of ¥988 million in the same period of the previous year. In addition, due to non-operating income and expenses and other factors, including ¥8 million in income from processing interruptions, up 13.7% year on year, and ¥9 million in losses on investment business partnerships, up 32.4%, ordinary loss was ¥1,043 million, compared with ordinary loss of ¥984 million in the same period of the previous year」

「Operating loss was ¥671 million, compared with an operating loss of ¥678 million in the same period of the previous year. In addition, due to non-operating income and expenses and other factors, including ¥7 million in income from processing interruptions, up 43.5% year on year, and ¥6 million in losses on investment business partnerships, down 3.3%, ordinary loss was ¥669 million, compared with ordinary loss of ¥676 million in the same period of the previous year.」

「In terms of profit and loss, due to higher revenue and other factors, gross profit was ¥46 million, up 16.1% year on year, while due to lower research and development expenses and other factors, selling, general and administrative expenses were ¥371 million, down 2.1%, resulting in operating loss of ¥325 million, compared with an operating loss of ¥339 million in the same period of the previous year. In addition, due to non-operating income and expenses and other factors, including ¥2 million in income from processing interruptions, down 4.8% year on year, and ¥4 million in losses on investment business partnerships, down 15.4%, ordinary loss was ¥324 million, compared with ordinary loss of ¥340 million in the same period of the previous year, and quarterly net loss was ¥325 million, compared with quarterly net loss of ¥342 million in the same period of the previous year.」

「Due to lower revenue and other factors, gross profit was ¥127 million, down 29.1% from the previous fiscal year, while selling, general and administrative expenses were ¥1,461 million, up 15.9% due to higher research and development expenses and other factors, resulting in operating loss of ¥1,333 million, compared with an operating loss of ¥1,080 million in the previous fiscal year.」

「Due to an increase in research and development expenses and other factors, selling, general and administrative expenses were ¥1,078 million, up 15.7% year on year, resulting in operating loss of ¥988 million, compared with an operating loss of ¥792 million in the same period of the previous year. In addition, due to non-operating income and expenses and other factors, including ¥7 million in income from processing interruptions and ¥7 million in losses on investment business partnerships, compared with gains of ¥209 million in the same period of the previous year, ordinary loss was ¥984 million, compared with ordinary loss of ¥577 million in the same period of the previous year, and quarterly net loss was ¥988 million, compared with quarterly net loss of ¥548 million in the same period of the previous year.」

「Due to an increase in research and development expenses and other factors, selling, general and administrative expenses were ¥746 million, up 25.5% year on year, resulting in operating loss of ¥678 million, compared with an operating loss of ¥545 million in the same period of the previous year.」

「Selling, general and administrative expenses were ¥379 million, up 15.7% year on year, resulting in operating loss of ¥339 million, compared with an operating loss of ¥306 million in the same period of the previous year.」

「Due to a significant decline in revenue and other factors, gross profit was ¥140 million, down 43.9% year on year, while selling, general and administrative expenses were ¥932 million, up 4.5%, resulting in operating loss of ¥792 million, compared with an operating loss of ¥642 million in the same period of the previous year.」

「Due to a significant decline in revenue and other factors, gross profit was ¥49 million, down 78.4% year on year, while selling, general and administrative expenses were ¥595 million, down 1.2%, resulting in operating loss of ¥545 million, compared with an operating loss of ¥372 million in the same period of the previous year.」

「Due to a significant decline in revenue and other factors, gross profit was ¥21 million, down 84.7% year on year, while selling, general and administrative expenses were ¥327 million, up 4.2%, resulting in operating loss of ¥306 million, compared with an operating loss of ¥172 million in the same period of the previous year.」

「Selling, general and administrative expenses were ¥892 million, down 19.9% year on year, and operating loss was ¥642 million, compared with an operating loss of ¥855 million in the same period of the previous year.」

「As a result of the effects of business structural reforms implemented in the previous fiscal year and other factors, gross profit was ¥229 million, up 29.8% year on year, selling, general and administrative expenses were ¥602 million, down 18.9%, and operating loss was ¥372 million, compared with an operating loss of ¥565 million in the same period of the previous year.」

「As a result of higher revenue and the effects of business structural reforms implemented in the previous fiscal year and other factors, gross profit was ¥142 million, up 81.1% year on year, selling, general and administrative expenses were ¥314 million, down 17.1%, and operating loss was ¥172 million, compared with an operating loss of ¥301 million in the same period of the previous year.」

「As a result, selling, general and administrative expenses were ¥1,408 million, down ¥1,622 million, or 53.5%, from the previous fiscal year, and operating loss was ¥1,008 million, compared with an operating loss of ¥2,714 million in the previous fiscal year.」

「In terms of profit and loss, operating loss was ¥855 million, while ordinary loss was ¥887 million due to non-operating expenses, including ¥30 million in foreign exchange losses, and other factors, reflecting the effects of implementing structural reforms and other factors.」

「In terms of profit and loss, operating loss was ¥565 million and ordinary loss was ¥578 million, reflecting the effects of implementing structural reforms and other factors.」

「As a result, selling, general and administrative expenses were ¥2,608 million, up ¥563 million year on year, and operating loss was ¥2,343 million, compared with an operating loss of ¥1,455 million in the same period of the previous year.」

「As a result, selling, general and administrative expenses were ¥2,116 million, up ¥683 million year on year, and operating loss was ¥1,914 million, compared with an operating loss of ¥1,036 million in the same period of the previous year.」

「As a result, selling, general and administrative expenses were ¥1,639 million, up ¥1,033 million year on year, and operating loss was ¥1,523 million, compared with an operating loss of ¥414 million in the same period of the previous year.」

「Operating loss was ¥1,801.535 million (operating loss of ¥1,681.103 million in the previous fiscal year).」

「In terms of earnings, SG&A expenses increased as the company added personnel to strengthen sales, while R&D expenses increased to advance the cellular medical products business. However, because it is taking longer than expected for these investments to produce results, the operating loss was ¥1,455 million, the ordinary loss was ¥1,399 million, and the net loss attributable to owners of the parent for the quarter was ¥1,417 million.」

「損益面では、営業活動の強化により販売費が増加し、細胞医療製品事業の推進のための研究開発費が増加したこと等により、営業損失は1,036百万円、経常損失は976百万円並びに親会社株主に帰属する四半期純損失は991百万円となりました。」

「The operating loss widened from the same period of the previous year due to higher SG&A expenses, but the ordinary loss and net loss attributable to owners of the parent for the quarter narrowed from the same period of the previous year due to higher non-operating income, including foreign exchange gains arising from the translation of foreign-currency-denominated long-term loans into yen.」

「As a result, selling, general and administrative expenses were ¥1,751,719 thousand, up ¥42,382 thousand, or 2.5%, year on year, and we recorded an operating loss of ¥1,135,734 thousand, compared with an operating loss of ¥1,192,866 thousand in the same period of the previous year.」